These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6440307)

  • 1. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
    Senogles SE; Nelsestuen GL
    J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
    Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
    J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of calcium-dependent binding of endogenous factor VIII/von Willebrand factor to surface activated platelets.
    Furby FH; Berndt MC; Castaldi PA; Koutts J
    Thromb Res; 1984 Sep; 35(5):501-11. PubMed ID: 6435280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.
    Nesheim M; Pittman DD; Giles AR; Fass DN; Wang JH; Slonosky D; Kaufman RJ
    J Biol Chem; 1991 Sep; 266(27):17815-20. PubMed ID: 1917924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J; Jordan J; Montgomery RR
    J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thrombin and ristocetin in the interaction between von Willebrand factor and platelets.
    Harrison RL; McKee PA
    Blood; 1983 Aug; 62(2):346-53. PubMed ID: 6307433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
    Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
    Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of blood platelets to human arterial subendothelium: role of factor VIII-Von Willebrand factor.
    Bolhuis PA; Sakariassen KS; Sixma JJ
    Haemostasis; 1979; 8(3-5):312-23. PubMed ID: 315905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor in the vessel wall mediates platelet adherence.
    Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
    Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.